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owHIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol
mobility in living cells creating a nanodomain
platform for virus assembly
C. Favard1*, J. Chojnacki2,3*, P. Merida1, N. Yandrapalli1, J. Mak4, C. Eggeling2,5,6†, D. Muriaux1†
HIV-1 Gag protein assembles at the plasma membrane of infected cells for viral particle formation. Gag targets
lipids, mainly PI(4,5)P2, at the inner leaflet of this membrane. Here, we address the question whether Gag is able
to trap specifically PI(4,5)P2 or other lipids during HIV-1 assembly in the host CD4+ T lymphocytes. Lipid dy-
namics within and away from HIV-1 assembly sites were determined using super-resolution microscopy coupled
with scanning fluorescence correlation spectroscopy in living cells. Analysis of HIV-1–infected cells revealed that,
upon assembly, HIV-1 is able to specifically trap PI(4,5)P2 and cholesterol, but not phosphatidylethanolamine or
sphingomyelin. Furthermore, our data showed that Gag is the main driving force to restrict the mobility of PI(4,5)P2
and cholesterol at the cell plasma membrane. This is the first direct evidence highlighting that HIV-1 creates its
own specific lipid environment by selectively recruiting PI(4,5)P2 and cholesterol as a membrane nanoplatform for
virus assembly.nloa
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 INTRODUCTION
During HIV-1 replication cycle, the assembly and release of newly
made viral particles occurs at the plasma membrane of the infected
cells (Fig. 1A). Budded HIV-1 particles display an unusual lipid
membrane composition that differs notably from that of the plasma
membrane of the host cell. It is enriched in sphingomyelins (SMs),
glycosphingolipids, cholesterol (Chol), and phosphoinositides, such
as phosphatidylinositol 4,5-bisphosphate lipid [PI(4,5)P2] (1, 2), and
characterized by highly ordered, i.e., densely packed, lipid organiza-
tion (1, 3). This raises the question on how virus components interact
with lipids in the plasma membrane of the host cells to gather such
specific lipid environment during assembly. For instance, PI(4,5)P2 is
recognized by the N-terminal region of HIV-1 Gag proteins that tar-
gets Gag to the plasma membrane (4–6). Then, studies of HIV-1 lipid
interactionsweremainly based on in vitromodel systems (7–11), tagged
phospholipid-interacting protein domains (12), or virus lipidomics
(1, 2, 7). However, direct observations of the relevant molecular in-
teractions in the living cells have long been challenged by the limited
spatial resolution of conventional optical microscopy. Fortunately,
recent advances in super-resolution microscopy techniques have
enabled for the characterization of molecular mobility at the nanoscale,
i.e., on the scale of individual (<140 nm) HIV-1 particles. For example,
experiments using a combination of super-resolution [stimulated emis-
sion depletion (STED) microscopy and fluorescence correlation spec-
troscopy (STED-FCS) (13) or scanning STED-FCS (sSTED-FCS) (14, 15)]
revealed a lowmobility ofmolecules on theHIV-1 surface (3) due to the
high degree of lipid packing in the virus membrane (15, 16).The retroviral protein Gag is thought to be a key player in altering
the HIV-1 lipid environment, as it is not only the main structural de-
terminant of the particle assembly but also mediates the interactions
between assembling virus particle and plasma membrane lipids.
HIV-1 Gag is composed of four domains (MA, CA, NC, and p6)
and two spacer peptides (sp1 and sp2). The MA domain of Gag is
myristoylated on its N terminus and contains a highly basic region
(named HBR), both responsible for Gag anchoring and targeting to
the cell plasma membrane (4–6, 17). The CA domain is involved in
the Gag-Gag interaction for multimerization. The NC domain is re-
quired for genomic RNA encapsidation and also for Gag-Gag multi-
merization through RNA (18). The p6, and part of the NC domain,
recruits host cell factors for particle budding (19). The space peptide
sp1 is also required for proper particle assembly and budding (20).
The binding of Gag to the plasma membrane is primarily resulting
from a bipartite signal withinMA [reviewed in (17)]. It is understood
that MA is thought to interact with the acidic lipids of the plasma
membrane inner leaflet (4), although recent studies suggest that
the NC domain of Gag could also play a role (21). Substitutions of
the MA basic residues have been shown to affect the targeting and
membrane binding of HIV-1 Gag both in liposomes (22) and in cells
(5). Furthermore, a lipidomic study has suggested that Gag interacts
with acidic phospholipids in cells, since virions produced by HIV-1–
infected cells were enriched in PI(4,5)P2 via anMA-dependent man-
ner (2), and this interpretation is supported by a recent report using a
tunable PI(4,5)P2 level to track Gag anchoring onto the cell mem-
brane via imaging analysis (23).
The unusual lipid contents in HIV-1 show that HIV-1 particles
require a specific lipid membrane environment for HIV-1 assembly.
A key question in HIV-1 assembly is whether Gag is targeted toward
preexisting lipid domains at the plasma membrane or whether Gag
actively creates its unique lipid compositions for virus formation. His-
torically, Gag has been shown to associate with the detergent-resistant
membrane fractions (24, 25), which are enriched in SM and Chol,
and raft properties of the virion-cholesterol impact on virus function
(26, 27). Saad et al. (28) have used truncated acyl chains PI(4,5)P2 to
show that the unsaturated sn-2 acyl chain of the PI(4,5)P2 is trapped
in an hydrophobic pocket, while the myristate is embedded into1 of 10
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 the lipid membrane, leaving the complex MA:PI(4,5)P2 to partition
to more liquid-ordered membrane environments. Using phase-
separated giant unilamellar vesicles (GUVs), Keller et al. (9) have shown
that multimerizable MA domains are partitioning into more liquid-
disordered membrane environments. In addition, using coarse-grained
molecular dynamics, researchers have highlighted that HIV-1 MA
interacts only with PI(4,5)P2 sugar head and that PI(4,5)P2 is con-
centrated within the immediate vicinity of MA (29). Recent nuclear
magnetic resonance studies on HIV-1 MA in interactions with lipidic
membranes confirmed these results and disproved the model that the
unsaturated sn-2 acyl chain of PI(4,5)P2 is trapped in a hydrophobic
pocket of MA (30). Last, our recent lipidic membrane–based study
demonstrated that recombinant HIV-1 Gag was able to segregate
PI(4,5)P2 and cholesterol-BOron-DIPYrromethene (BODIPY) fluo-
rescent analogs but excluded the BODIPY-SM analog upon Gag mul-
timerization and that Gag preferred to partition into the PI(4,5)P2
analog–enriched liquid-disordered lipid membrane environments
on GUVs rather than liquid-ordered lipid membrane environments
(10). Together, these results suggest that HIV-1 Gag may generate its
own PI(4,5)P2-enriched membrane environment at the cell plasma
membrane rather than assembling on preexisting areas or domains
with distinct lipid membrane environments. This is consistent with a
study using a biological tool to tune PI(4,5)P2 level at the cell plasma
membrane, and it was recently reported that PI(4,5)P2 not only targets
Gag to the cell membrane but also is necessary for assembly site for-
mation (23).
To study this dynamic equilibrium of Gag-lipid interaction in living
host CD4+ T cells, here, we use the super-resolution sSTED-FCS ap-
proach to analyze the mobility of fluorescent lipid analogs inside
and outside HIV-1 assembly sites on fluorescent Gag-labeled CD4
T cells infected by HIV-1 or expressing Gag only. We find that infec-
tious HIV-1 is able to immobilize PI(4,5)P2, and Chol, but not
phosphatidylethanolamine (PE) and SM analogs in these host cells
and that only Gag is required to restrict the movement of these lipid
molecules at the assembly sites. Our results highlight that HIV-1 Gag
selectively traps PI(4,5)P2 and cholesterol in host CD4T cells to create
its own specialized lipid membrane environment for virus assembly. 6, 2020RESULTS
PI(4,5)P2 and cholesterol, but not SM analogs, are trapped
during HIV-1 assembly in infected CD4+ T cells
Assembly of fully infectious HIV-1 particles requires a concomitant
assembly of viral Env and Gag/GagPol at the assembly site, i.e., at the
cellular plasma membrane, involving specific lipid environments
that can be either preexisting or generated by the viral proteins. To
distinguish these possibilities, we infected Jurkat CD4+ T lympho-
cytes with infectious NL4.3 HIV-1 viruses. These viruses expressed
green fluorescent protein (GFP), which was inserted between the MA
and CA domains of Gag (Gag-iGFP) (31). The concomitant fluores-
cence allowed for tracking the movement of fluorescently tagged lipids
at HIV-1 assembly sites (Fig. 1A).
Seventy-two hours after infection, we tested whether infected cells
are able to support HIV-1 assembly. Time lapse imaging at 37°C of cells
adhered to poly-L-lysine–coated coverslips highlighted that infected
cells produced newly appearing virus assembly sites within 20min after
adherence (Fig. 1B and movie S1) This is consistent with previous
HIV-1 assembly studies of HIV-1 particles (32) and HIV-1 Gag
virus-like particle (VLP) production in CD4+ T cells (33).Fig. 1. sSTED-FCS measurement of lipid diffusion inside and outside HIV-1
assembly sites. (A) Schematic illustration of Gag and Env distribution during HIV-1
assembly, release, and maturation. (B) Representative confocal time lapse images of
Jurkat T cells infected with NL4.3 Gag-iGFP HIV-1. On day 3 after infection, cells were
adhered to poly-L-lysine–coated coverslips and monitored for the appearance of
HIV-1 assembly sites prior to sSTED-FCS measurements. Images represent Gag-iGFP
signal (blue-green-yellow) at the cell-coverslip interface at 1 (left) and 20 min (right)
after adherence. Arrows indicate the appearance of the individual diffraction-
limited HIV-1 assembly sites, which were subsequently analyzed by sSTED-FCS. A
cell-free HIV-1 particle is indicated by an asterisk. Scale bar, 1 mm. (C) Left: Live
confocal imaging was used to localize HIV-1 virus assembly sites using Gag.iGFP
signal (blue-green-yellow) as a guide and to align them with the position of the
circular scan orbit (red dashed line). Right: Schematic illustration of sSTED-FCS orbit
over the HIV-1 assembly site. Arrows indicate the direction of the scan. Scale bar,
200 nm. (D to F) Representative confocal-mode signal intensity carpets for Gag.
iGFP signal (blue-green-yellow) before (D) and after (F) acquisition of STED-mode
intensity carpet for lipids (here, PE-ATTO647N) (E) inside and outside HIV-1
assembly sites. Image x and y axes correspond to the position on the scan line
and signal intensity at each time point, respectively. Scale bars, 200 nm (x axis;
white); 1.24 ms (y axis; gray). (G) Representative normalized autocorrelation curve
of PE-ATTO647N diffusion (gray line) obtained from a single position [marked by
the red asterisk in (C) and (D) to (F)] on the circular scan line within the correlation
carpet. Autocorrelation curve (red) was fitted using a generic 2D diffusion model.2 of 10
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 To visualize lipid mobility within or outside virus assembly sites,
we labeled the CD4+ T cells with fluorescent lipid analogs prior to
adhering cells to poly-L-lysine–coated coverslips. The selected ana-
logs correspond to lipids known to be enriched inHIV-1membranes
such as Chol and SM, to have a major role in Gag membrane inter-
action such as PI(4,5)P2, or to be selectively excluded inHIV-1mem-
branes such as PE. Figure S1 shows the structures of the lipid analogs
used. These analogs have been used multiple times before, and in
their cases, the dye label has been shown to have minimal influence
on the lipids’ membrane interaction dynamics (34–37). However,
the relatively large dye labels on the lipid analogs may prevent them
from entering highly ordered membrane environments [as high-
lighted before in (38)]. These highly ordered membrane environments
may also be created at the Gag assembly sites. However, as reported be-
low, we see distinct differences between different lipid types using the
same label, indicating that it is not the label but rather the lipid that is
dominating the organizational and interaction properties of the analog.
In addition, using classical spot FCS, we first confirmed that the mo-
bility of these lipid analogs in CD4+ T cells was comparable between
different dye labels, specifically to the mobility observed with
corresponding BODIPY-labeled lipids (fig. S2).
To acquire lipid analog mobility data via sSTED-FCS, we aligned
fluorescent HIV-1 assembly sites with the laser scanning orbit of our
microscope using a Gag-iGFP fluorescence signal as a guide (Fig. 1C).
Figure S2 highlights (for the case of the SM analog) that beam scanning
per se did not change the results obtained [as highlighted before in (14)].
In our current sSTED-FCSmeasurements, we first took larger confocal
microscope images identifying spots of GFP fluorescence as relevant
Gag clustering sites, and for subsequent analysis, we only selected newly
appearing (after cell adherence to the coverslip) small and immobile
(during the acquisition) Gag clusters at the T cell surface with low-
fluorescence Gag signal intensity. Previous studies have shown that
these sites represent virus assembly that is still in progress (32) and thus
minimize the risk of performing fluorescent lipid analog mobility anal-
ysis on the site of already budded virus particles (see also fig. S3). After
this identification step, the microscope was switched from imaging
(x and y axes) to continuous orbital line scanning (x and t axes, intensity
carpet acquisition) mode. Consequently, we recorded temporal fluores-
cence intensity fluctuations at each position (or pixel) along the scanned
orbit. An orbit always included Gag-clustering sites and thus HIV-1
assembly sites (GFP fluorescence) and areas without Gag (no GFP
fluorescence) (Fig. 1). We first acquired a short intensity carpet for
Gag fluorescence in a confocal mode to ensure that (i) the scanning or-
bit was correctly overlapped with the position of the virus assembly site
and (ii) the Gag assembly site was sufficiently immobile (no shift de-
tected along the x axis of the intensity carpet for Gag fluorescent signal)
to enable lipidmobilitymeasurements (Fig. 1D). Afterward, we acquired
an intensity carpet for the red emission signal of the fluorescent lipid
analogs with a reduced observation spot size (diameter, ~100 nm; STED
microscopy mode) (Fig. 1E). The reduced observation spot size ensured
that we are indeed mainly covering lipid data at the assembly site only
and not averaging over a larger nonrelevant area. Last, we again recorded
a fluorescence intensity carpet of Gag fluorescence in the confocal mode
to further ensure that the virus assembly site shows no detectable drift
during the whole acquisition process (Fig. 1F). The acquisition param-
eters for the recording of the fluorescent lipid analog data were chosen
for reducing bias and for generating accurate data: (i) The spot size of
100 nm in diameter ensured sufficient spatial resolution (fig. S4) for
distinguishing trapped from nontrapped lipids in and out of individ-Favard et al., Sci. Adv. 2019;5 : eaaw8651 2 October 2019ual virus assembly sites and yet had still high enough signal-to-noise
ratios for reasonable and reproducible FCS data (see error bars further
on). (ii) Orbital beam scanning with 3.23 kHz realized a low enough
dwelling at each scanned point to minimize (excitation and STED)
laser exposure and thus phototoxic effects (39), as well as a high enough
temporal resolution of the decaying FCS data (40). (iii) The number of
total points (30) per orbital scan facilitated the collection of sufficiently
enough data points for an accurate identification of the virus assembly
sites (14). FCS data were generated for each point along the orbital scan
and fitted with a generic two-dimensional (2D) diffusion model to ob-
tain the average transit times through the observation spot and the ap-
parent diffusion coefficient (Da) of the lipid analogs at each location
(Fig. 1G).
Figure 2 shows the change in lipid analog lateral mobility observed
in infected Jurkat T cells within (red boxes) and outside (green boxes)
the HIV-1 assembly sites. The lateral mobility of the lipid analogs as
measured in uninfected control cells is presented in blue. As previously
observed for ATTO647N-PI(4,5)P2 and TopFluor PI(4,5)P2 in
supported lipid bilayers (SLBs) [fig. S5 and (10)], the median diffusion
coefficient of ATTO647N-PI(4,5)P2 (Fig. 2A) within the assembly sites
was strongly reduced [Da = 0.02 mm
2/s, interquartile range (IQR) =
0.09 mm2/s] compared to the one observed outside the assembly sites
(Da = 0.17 mm
2/s, IQR = 0.31 mm2/s) or in HIV-1–negative cells
(Da = 0.20 mm
2/s, IQR = 0.30 mm2/s). Therefore, in infected Jurkat
T cells, the general mobility of ATTO647N-PI(4,5)P2 was decreased
8- to 10-fold within the assembly sites compared to elsewhere or in
HIV-1–negative cells. We further tested the Gag-specific mobility of
Chol. Chol has been shown to play a major role in the assembly pro-
cess of HIV-1 virus (24).Whenmonitoring the diffusion coefficient of
Chol-PEG-KK114 (Fig. 2B), we observed a similar decrease of Chol
analog mobility (Da = 0.10 mm
2/s, IQR = 0.20 mm2/s) within the as-
sembly sites compared to elsewhere (Da = 0.25 mm
2/s, IQR= 0.32 mm2/s)
and in HIV-1–negative cells (Da = 0.29 mm
2/s, IQR = 0.32 mm2/s). In
contrast, the ATTO647N-SM analog did not exhibit any significant
change in mobility in the presence or absence of HIV-1 or within and
outside the assembly sites (Da = 0.15 mm
2/s, IQR = 0.12 mm2/s and
Da = 0.17 mm
2/s, IQR= 0.16 mm2/swithin and outside the assembly sites,
respectively, and Da = 0.15 mm
2/s, IQR = 0.15 mm2/s in uninfected cells;
Fig. 2C). Similarly, we observed no significant change in the mobility of
the ATTO647N–1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine
(ATTO647N-DPPE) lipid analog within (Da = 0.32 mm
2/s, IQR =
0.31 mm2/s) versus outside (Da = 0.31 mm
2/s, IQR = 0.24 mm2/s) the
assembly sites or versus uninfected cells (Da = 0.31 mm
2/s, IQR =
0.18 mm2/s) (Fig. 2D).
We noticed that the values of the apparent diffusion coefficients
as determined from the sSTED-FCS (operating with a ~100-nm
large observation spot) were generally smaller (Da = 0.1 to 0.4 mm
2/s)
compared to data taken with confocal FCS (operating with a ~250-nm
large observation spot, Da = 0.7 to 1 mm
2/s; fig. S2). We have com-
pared values of Da for different observation sizes in STED-FCS
multiple times before to point out molecular diffusion modes of lipid
analogs in other cells and membranes (34). In the case of hindered
diffusion such as transient trapping, we congruently explored a
three- to six-times reduction of values of Da for observation spots
with diameters <100 nm compared to those determined for con-
ventional confocal spots (~250 nm). Such transient trapping was also
determined for most of the lipid analogs used here (34). Consequently,
values of Da determined for <100-nm observation spot sizes are
expected to be reduced compared to confocal recordings. However,3 of 10
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othe absolute values ofDa were of less relevance since we were interested
in highlighting changes in mobility between inside and outside Gag
assembly sites.
Expression of HIV-1 Gag alone is sufficient to immobilize PI
(4,5)P2 and cholesterol analogs during formation of VLPs
HIV-1 Gag alone is able to self-assemble at the plasma membrane
of the Jurkat T cells, leading to the generation of immature VLP.
Kerviel et al. (41) proposed that the self-association of Gag is suf-
ficient to generate a specific lipid environment. Therefore, by trans-
fecting the HIV-1 Gag.eGFP-only expression vector into Jurkat T cells
(for more details, see fig. S6) and measuring changes in the mobility of
lipids at Gag self-association sites, we tested whether the selective lipid
analog clustering that we have observed in HIV-1–infected cells (see
above) was also present in Gag-only assembly sites.
As with the infected Jurkat T cells, we first tested for the evidence
of appearance of VLP assembly sites at the surface of HIV-1 Gag-
expressing Jurkat cells (Fig. 3A), followed by the determination of
lipid analog diffusion coefficients both within and outside those sites.Favard et al., Sci. Adv. 2019;5 : eaaw8651 2 October 2019
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 We determined lipid diffusion at arbitrary sites in nontransfected
(non-Gag–expressing) cells as control. Figure 3 (B to E) depicts the
different values of diffusion coefficients determinedwithin (red boxes)
and outside the assembly sites ofHIV-1GagVLP (green boxes) and in
the nontransfected control cells (blue box). As observed in infected
cells, the lateral mobility of ATTO647N-PI(4,5)P2 was significantly
reduced inside (Da = 0.11 mm
2/s, IQR = 0.21 mm2/s) compared to
outside assembly sites or to nontransfected cells (Da = 0.24 mm
2/s,
IQR= 0.31mm2/s andDa = 0.20 mm
2/s, IQR= 0.30 mm2/s, respectively)
(Fig. 3B). However, the reduction in mobility between inside and
outside the assembly sites is only 2.2-fold (0.24/0.11) for T cells only
expressing HIV-1 Gag VLP in comparison with 8.5-fold (0.17/0.02)
forHIV-1–infectedT cells.Nevertheless, experiments onmodelmem-
branes support the direct role of Gag in this process of PI(4,5)P2
trapping. Upon addition of Gag to SLBs with 0.2% of fluorescent
PI(4,5)P2 analog, we observed the formation of ATTO647N-PI(4,5)P2
clusters at theGag binding sites with a concomitant sevenfold decrease
in PI(4,5)P2 analog mobility at these sites compared to elsewhere on
the SLBs or on SLBs in the absence of Gag (fig. S5). Also in line with
our data on infected T cells, we also observed a twofold reduction in
the lateral mobility for Chol-PEG-KK114 within the Gag assembly
sites (Da = 0.16 mm
2/s, IQR = 0.26 mm2/s) of HIV-1 Gag VLP only ex-
pressing T cells, compared to either outside the assembly site (Da =
0.30 mm2/s, IQR = 0.40 mm2/s) or in nontransfected control cells (Da =
0.29 mm2/s, IQR = 0.52 mm2/s; Fig. 3C). In contrast, ATTO647N-SM
and ATTO647N-DPPE (Fig. 3, D and E, respectively) again exhibited
no significant changes in their lateral mobility between HIV-1 Gag
self-assembly sites when compared to outside the sites or in non-
transfected cells (ATTO647N-SM: inside, Da = 0.16 mm
2/s, IQR =
0.33 mm2/s; outside,Da = 0.14 mm
2/s, IQR = 0.34 mm2/s; nontransfected,
Da = 0.14 mm
2/s, IQR = 0.30 mm2/s; ATTO647N-DPPE: inside, Da =
0.46 mm2/s, IQR = 0.38 mm2/s; outside, Da = 0.24 mm
2/s, IQR =
0.34 mm2/s; nontransfected, Da = 0.50 mm
2/s, IQR = 0.47 mm2/s).
HIV-1 Gag is the primary determinant of lipid trapping
efficiency at HIV-1 assembly sites in CD4+ T cells
The decrease in the lateral mobility of ATTO647N-PI(4,5)P2 and
Chol-PEG-KK114 at Gag assembly sites suggests trapping of these
lipid analogs during virus particle formation. To further quantify this
restricted diffusion, we used a confinement index based on normal-
ized relative cumulative frequency histograms of the values of the
diffusion coefficient Da (for Da = 0.001 to 1 mm
2/s, normalized to
100 for Da = 1 mm
2/s). Representative cumulative frequency histo-
grams for diffusion within and outside the assembly sites are shown
in figs. S7 and S8, respectively, highlighting a huge difference for
PI(4,5)P2 and Chol (but not for SMand PE) analogs. To further spec-
ify this difference, we classified three diffusion regimes, “fast,”
“intermediate,” and “slow”mobility, for respective values ofDa < 0.01,
0.01 ≤ Da < 0.1, and Da ≥ 0.1 mm
2/s, we calculated the sum of
cumulative frequencies within each regime, and we plotted the con-
finement index for each regime as the ratio of the latter values for
lipid diffusion within and outside the assembly sites or within the
assembly sites and noninfected (or nontransfected) cells. For an
increased confinement of lipids inside the assembly sites, we would ex-
pect a larger relative fraction of low values of Da, i.e., an increased frac-
tion and thus confinement indices >1 within the intermediate and
especially the slow mobility regimes (and consequently a reduced frac-
tion and thus a confinement index <1 within the fast regime). In con-
trast, similar cumulative frequency histograms and thus confinementFig. 2. Lipidmobility changes inNL4.3 Gag-iGFPHIV-1–infected Jurkat T cells.
Median lipid diffusion coefficients (Da) as determined by sSTED-FCS measure-
ments of 20 sites each from two independent virus preparations and infections.
Box-and-whisker plots (horizontal line, median; box, 25 to 75% percentiles or IQR;
whiskers, 10 to 90% measurements) showing Da values inside assembly sites (red),
outside assembly sites (green), and in noninfected control cells (blue). Data were
collected for (A) ATTO647N-PI(4,5)P2, (B) cholesterol (Chol-PEG-KK114), (C) SM
(ATTO647N-SM), and (D) PE (ATTO647N-DPPE) analogs. Statistical significance
was assessed by Wilcoxon rank sum test. ns, not significant.4 of 10
SC I ENCE ADVANCES | R E S EARCH ART I C L Eindices ≈1 for all regimes indicate no change in mobility and thus no
confinement within the assembly sites. As expected, the various values
of confinement indices confirm our previous conclusion, i.e., that
ATTO647N-SM and ATTO647N-DPPE did not exhibit any con-
finement within assembly sites, while ATTO647N-PI(4,5)P2 and
Chol-PEG-KK114 revealed a drastic reduction of lateral mobility and
thus confinement at the assembly sites.Favard et al., Sci. Adv. 2019;5 : eaaw8651 2 October 2019When we compared the confinement index values obtained for
the different lipids in HIV-1 Gag-transfected cells (Fig. 4, gray bars)
against those in HIV-1–infected cells (Fig. 4, black bars), we ob-
served similarities between these two conditions. Specifically, both
PI(4,5)P2 and Chol analogs have values of high confinement indices
>1 in the intermediate and slow regimes for both HIV-1–infected
and Gag-only–expressing T cells, while confinement index values
≈1 are conserved for both SM and PE analogs. This highlights that
the HIV-1 Gag protein on its own seems to be sufficient to facilitate
the confinement or trapping of cholesterol and PI(4,5)P2 analogs in
HIV-1 assembly sites, and no other molecular factor only present in
infected cells (and not in the Gag-only case) is required.http://advanc
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 DISCUSSION
How enveloped viruses acquire their lipid membrane shell is of great
importance for their biogenesis and their capacity to infect cells. In
the case of HIV-1, recently, it has been shown that the envelope lipid
composition was a determinant of lowmolecular mobility of the Env
protein (3, 16). Several works have been conducted to reveal different
envelope viruses having their own unique lipid composition (2, 7, 9, 42),
implying their distinct biological requirements during infection, and
suggesting their capacity in sorting specific host lipids into their virus
membrane. Two main lipids and a sterol have been described to play a
major role for HIV-1 biogenesis and infectivity. PI(4,5)P2 is known to
be the plasma membrane lipid targeted by the MA domain of the poly-
protein Gag (5, 22, 28, 43). SM- and cholesterol-enriched lipid envir-
onments, often denoted “raft-like” domains [rafts used to be defined o
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ag.org/Fig. 4. Lipid trapping induced by Gag during HIV-1 assembly in infected or
transfected Jurkat T cells. Confinement indices are based on the relative nor-
malized cumulative frequency distribution of the diffusion coefficients Da (for
Da = 0.001 to 1 mm
2/s, normalized to 100 for Da = 1 mm
2/s), which were arbitrarily
divided into three distinct diffusion regimes, slow (Da < 0.01 mm
2/s), intermediate
(0.01 ≤ Da < 0.1 mm
2/s), and fast (Da ≥ 0.1 mm
2/s). The sum of cumulative frequen-
cies within each regime resulted in values of the confinement index for each re-
gime as ratio of the latter values for lipid diffusion within and outside the
assembly sites or within the assembly sites and noninfected (or nontransfected)
cells. Values of the confinement indices found for PI(4,5)P2, Chol, SM, and PE ana-
logs for HIV-1 Gag.eGFP-transfected (black bars) and HIV-1-iGFP–infected (gray
bars) Jurkat T cells. Chol and PI(4,5)P2 analogs show strong confinement (indices
>1 for intermediate and especially slow regimes) inside assembly sites for both
transfected-only or fully infected Jurkat T cells, while neither SM nor PE analogs
exhibited confinement inside assembly sites (confinement index ~1 for all regimes).
*, no diffusion coefficients below 0.01 mm2/s were observed for PE analogs.Fig. 3. Lipid mobility changes in HIV-1 Gag.iGFP transfected Jurkat T cells.
(A) Representative live confocal image of Jurkat T cells expressing HIV-1 Gag.iGFP.
Image represents Gag.iGFP signal (blue-green-yellow) at the cell-coverslip
interface at 24 hours after transfection. Scale bar, 1 mm. Zoomed-in confocal
image depicts an individual HIV-1 assembly site indicated by an arrow. Scale
bar, 200 nm. (B to E) Median values of the lipid diffusion coefficients (Da) were
determined for (A) ATTO647N-PI(4,5)P2, (B) cholesterol (Chol-PEG-KK114), (C) SM
(ATTO647N-SM), and (D) PE (ATTO647N-DPPE) analogs by sSTED-FCS on 20 sites
each from two independent Gag.iGFP transfections. Box-and-whisker plots (hor-
izontal line, median; box, 25 to 75% percentiles or IQR; whiskers 10 to 90% mea-
surements) showing Da values inside assembly sites (red), outside assembly sites
(green) and in untransfected control cells (blue). Statistical significance was as-
sessed by Wilcoxon rank sum test.5 of 10
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 as small (10 to 200 nm), heterogeneous, highly dynamic, sterol- and
sphingolipid-enriched domains that compartmentalize cellular pro-
cesses (44)], have also been described as essential for envelope retrieving
(45), HIV-1 assembly (24, 46, 47), or infectivity (26, 27).
Whether a preexisting lipid nanodomain or a virus-induced lipid
platform is the source of virion lipidmembrane duringHIV-1 forma-
tion is a matter of debate (36). We proposed that the Gag protein is
the source of the viral lipid envelope upon assembly (10, 41), as also
just proposed by another group (48). Lipid sorting and lipid domain
generation in viral assembly can be identified by nanoscale spatial
changes in lipid mobility at the plasma membrane (13, 14), and
our super-resolution microscopy–based approaches for the analysis
of the lipid dynamics in living cells represent themost relevantmodel of
observation.
In this study, we have determined the diffusion coefficients of flu-
orescent lipid analogs by applying sSTED-FCS on HIV-1–infected,
fluorescent Gag-expressing, and HIV-1–negative CD4+ Jurkat T cells.
The sSTED-FCS approach allows for a direct simultaneously quantita-
tive comparison of lipid analog mobility both within and outside
assembly sites at the plasma membrane.
In comparison with the plasma membrane of HIV-1–negative
cells or plasma membrane regions outside HIV-1 assembly sites,
the mobility of PI(4,5)P2 and Chol analogs within viral assembly
sites is drastically reduced (up to 10 times decrease of median Da).
The same trend was observed on the assembly site of Gag VLPs in
cells expressing only Gag. Although to a less extent than in HIV-1–
producing cells, the median values of the diffusion coefficients of PI
(4,5)P2 and Chol analogs were significantly reduced in the VLP
assembly area. In contrast, the mobility of neither fluorescent SM
nor neutral lipid PE analogs exhibited any variation inmedian values
for both HIV-1–producing and Gag VLP–producing cells.
It has been recently shown that diffusion coefficient distributions
could unravel the nature of lipid motions (49). Therefore, to allow
direct comparison of the virus component effect on lipid analog mo-
bility, independently of the cell or the number of expressed com-
ponent (Gag alone or infectious virus), a confinement index was
defined. As in more detail described within the result section, it is
based on the relative changes in three different parts of the normal-
ized cumulative distribution of the logarithm of the diffusion coeffi-
cients observed inside and outside the virus or VLP assembly site.
The value of this confinement index into these three parts reflects
the relative change in mobility of the lipid analogs that are trapped
(slow,Da < 0.01 mm
2/s), confined (intermediate, 0.01 <Da < 0.1 mm
2/s),
or freely diffusing (fast, Da > 0.1 mm
2/s) at the assembly sites. By defi-
nition, the confinement indexwill be equal to 1 if no effect occurs on the
lipid mobility inside the assembly when compared to outside the
assembly site. This unit value was always observed with the fluorescent
PE lipid analog, which is generally used as a control of free diffusing
lipid in cell plasma membranes (13) and is not described as being
enriched in HIV-1 envelopes (1, 7).
Among the different fluorescent lipid analogs tested here, the
PI(4,5)P2 exhibited the strongest confinement index for the slow part
of the distribution, (confinement index, ~10) both for HIV-1 virus
and VLP assembly sites in CD4+ T cells. This reveals that the transient
binding of PI(4,5)P2 to aggregating Gag conjugated PI(4,5)P2 into
the nascent virion or the VLP. This assembly site–specific trapping
of PI(4,5)P2 seems to be indeed exclusive to Gag, since the observed
confinement indices showed the same trend independent of as-
sembling HIV-1 or VLPs. Moreover, similar confinement indices wereFavard et al., Sci. Adv. 2019;5 : eaaw8651 2 October 2019observed on the SLB in the in vitro system tested here, i.e., SLBs made
of PC, PS, and fluorescent PI(4,5)P2 with or without addition of self-
assembling HIV-1 Gag protein (see section S2).
Similar to PI(4,5)P2, the confinement index of the slow diffusing
fluorescent Chol analog was also above 1 in infected cells, as well as in
transfected cells, confirming that Chol is trapped during HIV-1
assembly and that Gag alone is sufficient to restrict cholesterol mobility
at the assembly site. Consequently, the restriction of PI(4,5)P2 andChol
seems to be independent of non-Gag viral proteins, such as HIV-1 Env
or accessory/regulatory proteins.
Using in vitro lipid membrane models of different lipid com-
positions, we recently reported (10) that Gag was able to generate
TF-PI(4,5)P2 and TF-cholesterol but not TF-SM–enriched lipid
nanodomains. This is consistent with data observed here in HIV-1–
producing or Gag-expressing CD4+ T cells, even with lipid analogs
grafted with different fluorophores. Notably, such local enrichment
of PI(4,5)P2 and Chol lipid at virus assembly sites has been predicted
using coarse-grained molecular dynamics in the case of the matrix
self-assembly of Ebola virus (50), implying a potential general mech-
anism for a number of enveloped viruses that bud from the host cell
plasma membrane.
Enrichment of specific lipid in HIV-1 viruses has already been
reported (1, 2, 7), but the mechanism by which these lipids are in-
corporated into the virus envelope was so far unknown and has
now been discussed by our present work and the one just released
by Sengupta et al. (48). Different values of virion lipid enrichment
have been found, depending on the cell lines and the biochemical
methods to purify viruses or isolate plasma membranes from the
other cell membranes (1, 2, 7). In H9 T lymphocytes, Chan et al. (2)
have shown that HIV-1 lipid envelope is two times higher in PI(4,5)P2
and three times higher in cholesterol when compared to the plasma
membrane of the HIV-1–producing H9 cells. Our results show that
this enrichment occurs during virus assembly. Sequestration of
PI(4,5)P2 in the plasma membrane in the vicinity of PI(4,5)P2
binding proteins or peptide has already been shown and modeled
a decade ago (51). Using coarse-grained dynamic modeling, we also
previously reported the sequestration of PI(4,5)P2 upon binding of
the MA domain of Gag to lipid membranes. Given that PI(4,5)P2 is
important for the binding of Gag to the cell plasma membrane (5),
the clustering of PI(4,5)P2 at the cell membrane may provide an ad-
ditional mechanism to further concentrate Gag, thereby enhancing
virus assembly. Furthermore, molecular simulations of PI(4,5)P2
clustering have revealed the induction of negative membrane curva-
ture (52) by PI(4,5)P2, which could facilitate the formation of spheri-
cal particle morphogenesis during virus assembly.
Cholesterol has been shown to play a role in HIV-1 Gag matrix do-
main (MA) binding to membranes (8, 53), as well as in the stabilization
of PI(4,5)P2 lipid nanodomains in the absence of proteins (52). A role for
the Chol can be proposed on the basis of the work of Doktorova et al.
(54) on Rous sarcoma virus MA-membrane interactions, which can be
generalized to other retroviruses. Using molecular dynamics simula-
tions, Doktorova and collaborators showed that the MA domain of
the retroviral Gag protein interacts better with the charged head of
phosphatidylserine (PS) phospholipids of the membrane in the pres-
ence of Chol. They proposed that Chol would increase lipid packing
and membrane surface charge density, facilitating MA association to
membrane. We previously reported the concomitant trapping of Chol
and PI(4,5)P2 analogs by HIV-1 Gag in vitro on SLBs upon Gag multi-
merization (10). Thus, the trapping of both PI(4,5)P2 and Chol by6 of 10
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 HIV-1 Gag that we observe in CD4 T cells could also favor Chol en-
hancing locally PI(4,5)P2 clustering and making membrane surface
more negative: This combination would favor the targeting and the
next assembling of Gag molecules at the viral bud through the en-
hancing of MA positively charged membrane interactions.
It has been suggested for a long time that preexisting SM-Chol–
enriched cell plasma membrane domains (so-called “raft” domains)
could play a role in HIV-1 assembly [reviewed in (45)]. The recently
released work of Sengupta et al. (48) proposed that, during Gag self-
assembly in adherent cells, the immobilization of PI(4,5)P2, naturally
bearing a long C18 acyl chain in the sn-1 position, could generate trans-
bilayer coupling bymeans of an interdigitationmechanismwith the SM
acyl chains, inducing the recruitment of the SM-Chol enriched domains
present in the outer leaflet and leading, therefore, to specific recruit-
ment in the budding site of raft-partitioning proteins. To verify this
hypothesis in T cells, we also assessed changes in fluorescent SM analog
dynamics at the virus assembly site using our sSTED-FCS approach. The
observed confinement indices of the SM analog were never above 1,
highlighting that HIV-1 assembly had no direct effect on the SM mo-
bility at theCD4+T cell plasmamembrane.Our results, considering this
lack of SM enrichment in CD4 T cells at the HIV-1 budding sites, is in
line with recent lipidomics data (7), our previous finding of SM exclu-
sion during the time course of HIV-1 Gag assembly on SLBs (10), and
the already observed exclusion of SM in curved membranes (55). The
exact role of SM in HIV-1 assembly in T cells is therefore still an open
question (56).
Cholesterol has also been proposed to play a major role in inter-
leaflet coupling of lipid membranes (57). Thallmair et al. (58) has
shown that cholesterol could serve as an efficient signaling molecule
transferring information between the leaflets while populating the
interleaflet space. It has been previously shown that cholesterol was
enriched at the center of polyunsaturated lipid membranes, an acyl
chain naturally present in the sn-2 position of PI(4,5)P2 (59). This pos-
sible repositioning of cholesterol in the middle of themembrane, due to
the strong PI(4,5)P2 trapping at the budding site, will facilitate choles-
terol flip-flop, resulting in its local enrichment in the outer leaflet and
the generation of an outer leaflet liquid-ordered domain without the
need of any additional SM.
Overall, our results provide direct evidence that HIV-1 Gag as-
sembly drives the lipid sorting in host CD4 T cell plasma membranes
and creates its own PI(4,5)P2/cholesterol lipid-enriched membrane
environment likely to provide a positive feedback loop to recruit addi-
tional Gag proteins at the budding site through the PI(4,5)P2-MA do-
main of Gag interactions for the biogenesis of HIV-1 particles.
Moreover, the cholesterol enrichment observed here could play amajor
role in the lipid bilayer transmembrane coupling mechanism needed to
retrieve specific HIV-1 envelope proteins.MATERIALS AND METHODS
Experimental design
Themain goal of this studywas to unravel whether the viral Gag protein
is targeted toward preexisting lipid domains at the host cell plasma
membrane thatwill help inHIV-1 assembly,or whether, in the opposite,
Gag creates its own lipid domain during virus formation. To do so, we
measured the change in mobility of different lipid analogs at HIV-1
assembly sites.We used fluorescent lipid analogs described to play a role
either inGagmembrane targeting [PI(4,5)P2] and assembly (cholesterol)
or known to be a part of preexisting lipid domains at the plasma mem-Favard et al., Sci. Adv. 2019;5 : eaaw8651 2 October 2019brane (SM) and, finally, a control lipid (PE) not described to play a role
in any of the two possible mechanisms. To achieve our goal, our exper-
imental setup was based on a direct measurement of apparent diffusion
coefficient of the lipid analogs inside and outsideHIV-1 fluorescentGag
assembly sites using spatial scanning FCS on a super-resolution STED
microscope (delivering an observation spot size of around 100 nm in
diameter, i.e., below that of a conventional microscope). Our measure-
ments were performed in HIV-1–infected CD4 T cells and as a control
in CD4 T cells expressing Gag-iGFP only. Last, using a top-bottom ap-
proach of purified HIV-1 Gag on fluorescent PI(4,5)P2-SLBs, we could
highlight that Gag was sufficient to generate a PI(4,5)P2-nanodomain
platform for assembly.
Lipids and fluorescent lipid analogs
Lipids 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), brain L-
a-PS, and brain PI(4,5)P2 were purchased from Avanti Polar Lipids
(Alabaster, AL, USA). ATTO647N-DPPE and ATTO647N–SM
(ATTO647N-SM) were purchased from ATTO-TEC GmbH (Siegen-
Weidenau, Siegen, Germany). Abberior STAR RED (KK114)–1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine (KK114-DPPE),
cholesterol–PEG(1 k)-Abberior STAR RED (KK114) [Chol-PEG(1 k)-
KK114], and ATTO647N-PI(4,5)P2 [ATTO647N-PI(4,5)P2] were all
purchased from Abberior GmbH (Göttingen, Germany). Chemical
structures of all the lipid analogs used in this study are given in fig. S1.
Gag protein and SLBs
Full-length Gag protein had been produced and purified as described
previously (10). SLBs for Gag lipid clustering measurements were
prepared from 30-nm small unilamellar vesicles (SUVs) with the
following: DOPC, 68%; PS, 30%; PI(4,5)P2, 1.9%; and ATTO647N-
PI(4,5)P2, 0.1%mol at 0.1mg/ml in a citrate buffer [10mMNa citrate,
100 mM NaCl, and 0.5 mM EGTA (pH 4.6)]. The SUVs were then
spread for 45 min at 37°C on coverslips pretreated by sonication in
5% SDS solution and incubation for 30 min in freshly made piranha
solution (H2SO4:H202 2:1 vol). After disposition of the SLBs,
scanning FCS measurements were performed and again 15 min after
Gag was added at 1 mM final concentration.
Plasmids
Plasmid expressing fully infectious Jurkat T cell tropic NL4.3 HIV-1
Gag-iGFPwas previously described (31) and was a gift from B. Chen.
Plasmid expressing NL4.3 HIV-1 Gag-eGFP fusion protein was pre-
viously described (60) and was a gift from H. de Rocquigny.
Cell culture
Jurkat T cells (human T cell leukemia cell line–ATCC TIB-152) were
grown in RPMI 1640 with GlutaMAX (Gibco), supplemented with
10% fetal calf serum, and penicillin-streptomycin (100 U/ml) and
20 mM Hepes (pH 7.4). Cells were maintained at 37°C, 5% CO2.
NL4.3 HIV-1 Gag.iGFP particle preparation
Fully infectious NL4.3 HIV-1 Gag-iGFP particles were prepared
from the tissue culture supernatant of 293 T cells transfected using
polyethyleneimine with 15 mg of pNL4.3 HIV-1 Gag-iGFP plasmid.
Tissue culture supernatants were harvested 48 hours after transfec-
tion, and particles were concentrated using a Lenti-X Concentrator
reagent (Clontech) according to the manufacturer’s instructions.
Concentrated particles were snap-frozen and stored in aliquots at
−80°C.7 of 10
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 Jurkat T cell infection
Jurkat CD4+ T cells were infected by incubation of 1 million cells with
HIV-1 NL4.3 Gag-iGFP particles in 50 ml of RPMI medium for 1 hour
at 37°C. Cells were washed three times in RPMI medium and then
cultured for 72 hours at 2 million cells per milliliter to achieve a 5 to
10% infection rate with progeny virus production.
Jurkat T cell transfection
Jurkat T cells (2 × 106) were microporated with 4 mg of plasmid
expressing NL4.3 HIV-1 Gag.eGFP using the AMAXA system
(Lonza), as previously described in (33). After microporation,
Jurkat T cells were incubated in RPMI complete medium and har-
vested 24 hours after transfection for microscopy acquisitions as de-
scribed in the following sections. For supplemental information
concerning the choice of the transfected Jurkat T cells expressing
Gag.eGFP, see fig. S6.
Microscope setup
sSTED-FCS measurements were performed on the Abberior Instru-
ment Expert Line STED super-resolution microscope (Abberior
Instruments GmbH, Göttingen, Germany) using 485- and 640-nm
pulsed excitation laser sources and a pulsed STED laser operating at
775 nm and an 80-MHz repetition rate. The fluorescence excitation
and collection were performed using a 100×/1.40 numerical aperture
(NA) UPlanSApo oil immersion objective (Olympus Industrial,
Southend-on-Sea, UK). All acquisition operations were controlled
by Imspector software (Abberior Instruments GmbH), and point
FCS data for the calibration of the observation spot sizes were re-
corded using a hardware correlator (Flex02-08D, correlator.com, op-
erated by the company’s software).
Confocal microscope FCS measurements were performed on a
Zeiss LSM 780 (Zeiss, Iena, Germany) using a HeNe 633-nm laser
as the excitation source. Fluorescence excitation and collection were
performed using a 63×/1.40-NA PlanApo oil immersion objective
(Zeiss). Acquisition operations were controlled by the Zeiss Zen
software. Point FCS was used to calibrate the observation spot with
the LSM 780 internal hardware correlator.
Microscope sample preparation
For calibration of the observation spot sizes using STED-FCS, SLBs
were prepared, as previously described (61), by spin-coating a cover-
slip with a solution of DOPC (1 mg/ml) and KK114-DPPE (0.5 mg/ml)
in CHCl3/MeOH. Coverslips were cleaned by piranha solution (3:1 sul-
furic acid and hydrogen peroxide). The lipid bilayer was formed by re-
hydrating with SLB buffer containing 10mMHepes and 150mMNaCl
(pH 7.4). Calibration of the confocal observation spot size was made
with a 50 nM solution of rhodamine in pure water using D =
280 mm2/s as the diffusion coefficient.
For lipid mobility measurements inside and outside Gag assembly
sites in mammalian cells, 3 × 105 Jurkat T cells 72 hours after infection
with NL4.3 HIV-1 Gag-iGFP virus particles or 24 hours after transfec-
tion with NL4.3 HIV-1 Gag-eGFP–expressing plasmid were resus-
pended in 200 ml of Leibovitz’s L-15 medium (Sigma-Aldrich) and
incubated with 25 nM of the indicated fluorescent lipid analog probe
for 5 min at 37°C. Cells were then washed three times in suspension
in L-15 medium, resuspended in 250 ml of L-15 medium, and adhered
to solution poly-L-lysine (0.1 mg/ml) (Sigma-Aldrich)–coated glass
surface of eight-well Ibidi m-Slides (Ibidi, Martinsried, Germany) at
37°C 30 min prior to microscopy measurements.Favard et al., Sci. Adv. 2019;5 : eaaw8651 2 October 2019For lipid mobility measurements on myr(−) Gag containing SLBs,
prior to experiments, citrate buffer was changed to protein buffer
[10 mMHepes (pH 7.4), 150 mMKCl, and 2 mM EDTA], followed
by injection of 1 mM myr(−) Gag.
sSTED-FCS signal acquisition
sSTED-FCS data of the lipid mobility inside and outside Gag
assembly sites in Jurkat T cells were acquired at 37°C using fluorescent
Gag signal as a guide. Fluorescent lipid signal intensity fluctuation
carpets (scanning an orbit multiple times) were recorded using the
Imspector software with the following parameters: orbital scan fre-
quency, 3.23 kHz; scan orbit length, 1.5 mm; pixel dwell time, 10 ms;
total measurement time, 10 s; pixel size, 50 nm per pixel, 10-mW ex-
citation power (back aperture), 640 nm; and observation spot diame-
ter, 100 nm (full width at half maximum) FWHM (as determined by
SLB calibrationmeasurements; section S1). The scan frequency selected
for these experimentswas set sufficiently high to enable the extraction of
the diffusion dynamics of fluorescent lipid analogs in the cell plasma
membrane (14).
FCS curve autocorrelation and fitting
The FoCuS-scan software (40) was used to autocorrelate the sSTED-
FCS data and to fit it with a classical 2D diffusion model
GNðtÞ ¼ Gð∞Þ þ GNð0Þ 1þ ttxy
 1
ð1Þ
where GN(t) is the correlation function at time lag t, G( ∞ ) is the
offset, GN(0) is the amplitude, and txy is the average lateral transit
time through the observation spot. As done in all previous sSTED-
FCS measurements, we left out anomaly factors in the fitting equa-
tion (as often done in nonscanning single-point STED-FCS data),
since the decay of the sSTED-FCS curves starts at 0.5- to 1-ms cor-
relation times only and because anomaly is much better revealed by
comparing (cumulative) frequency histograms of resulting param-
eters (14). Last, regarding the noise in our correlogram, we discarded
all the fitted correlations times smaller than 2 ms, resulting in a trun-
cated distibution of the correlation times. The corresponding values
of the apparent molecular diffusion coefficient (Da) were calculated
from txy
Da ¼ FWHM2=8lnð2Þtxy ð2Þ
where FWHM represents the usual full-width half maximum of the
observation spot (100 nm; see section S4).
Calculation of the confinement index
Diffusion coefficients obtained for the different lipid in the differ-
ent conditions tested were binned in groups every 10−3 mm2/s from
0 to 1.2 mm2/s. The distribution was cumulated and normalized. It
was then split into three parts: slow (Da < 10
−2 mm2/s), intermediate
(10−2 ≤ Da < 10
−1 mm2/s), and fast (Da ≥ 10
−1 mm2/s). The relative
proportion (Pi) of the total distribution (0 ≤ Pi ≤1) of each of these
parts was then calculated for each molecule inside the assembly
site, outside the assembly site, and in noninfected or transfected
cells. The confinement index is defined for each of the three parts
as the quotient of the Pi value found inside the assembly site over8 of 10
SC I ENCE ADVANCES | R E S EARCH ART I C L Ethe Pi value found outside the assembly site or in noninfected or
transfected cells (Fig. 4).
Statistical analysis
Because of the non-Gaussian nature of the diffusion coefficient
data distribution, Wilcoxon rank sum test was used with the result
P < 0.05 considered statistically significant. Statistical tests were
performed using GraphPad Prism software. Power calculations
confirmed that, for chosen sample sizes, the power of a two-sided
hypothesis test at the 0.05 significance was over 90%. In all com-
pared groups, IQR serves as an estimate of variation. IQRs were
similar in all compared groups. o
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 SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/10/eaaw8651/DC1
Sections S1 and S2. Characterization of fluorescent lipid analogs
Section S3. MHC-I mobility at HIV-1 assembly sites in NL4.3 Gag-iGFP HIV-1–infected
Jurkat T cells
Section S4. STED microscope calibration
Section S5. PI(4,5)P2 clustering and trapping by full-length HIV-1 Gag on biomimetic
membranes
Section S6. Budding efficiency comparison in Jurkat T cells transfected with Gag.eGFP or with
a mixture of Gag.eGFP/Gag (ratio, 1:3)
Section S7. Cumulative frequency distributions observed in infected cells for the different
lipids
Section S8. Cumulative frequency distributions observed in transfected cells for the different
lipids
Fig. S1. Fluorescent lipid analog structures.
Fig. S2. Fluorescent lipid analog mobility in Jurkat T cells.
Fig. S3. MHC-I mobility at HIV-1 assembly sites in NL4.3 Gag-iGFP HIV-1–infected Jurkat T cells.
Fig. S4. STED microscope calibration results.
Fig. S5. Changes in the lateral mobility of ATTO647N-PI(4,5)P2 upon addition of Gag on SLBs.
Fig. S6. Jurkat T cell coelectroporation with Gag.eGFP and Gag plasmids.
Fig. S7. Cumulative frequency distributions of diffusion coefficient observed in HIV-1–infected
T cells.
Fig. S8. Cumulative frequency distributions of diffusion coefficient observed in HIV-1 Gag-
transfected T cells.
Movie S1. Drift stabilized time lapse movie of a representative NL4.3 Gag-iGFP HIV-1–infected
Jurkat T-cell showing already present and newly developing virus assembly sites.
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